Showing results (171-180 of 529) with videos related to
Sort By:
Pageof 53
Emerging Infectious Diseases|December 19, 2001
Potential infectious etiologies of atherosclerosis: a multifactorial perspectiveS O'Connor, C Taylor, L A Campbell, et al.The Journal of Biological Chemistry|July 14, 1995
Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cellsH B Peng, T B Rajavashisth, P Libby, et al.Journal of the American College of Cardiology|March 21, 1998
Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeysJ K Williams, G K Sukhova, D M Herrington, et al.Proceedings of the National Academy of Sciences of the United States of America|June 22, 2000
Inhibition of CD40 signaling limits evolution of established atherosclerosis in miceU Schönbeck, G K Sukhova, K Shimizu, et al.The New England Journal of Medicine|June 9, 1988
Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheromaP Libby, S J Warner, R N Salomon, et al.Circulation Research|December 1, 1998
Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cellsN Marx, U Schönbeck, M A Lazar, et al.The American Journal of Cardiology|March 6, 1997
Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery diseaseA P Selwyn, S Kinlay, M Creager, et al.Circulation|December 1, 1992
A cascade model for restenosis. A special case of atherosclerosis progressionP Libby, D Schwartz, E Brogi, et al.The American Journal of Medicine|April 29, 1998
Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilizationP Libby, U Schoenbeck, F Mach, et al.Atherosclerosis|February 5, 2000
Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic miceR P Fabunmi, K J Moore, P Libby, et al.Pageof 53